Loading...
Strategies are available to prevent HIV transmission during pregnancy and delivery, but less is known about reducing risk during breast-feeding. Now, data from the Mma Bana study — presented by Roger Shapiro and colleagues at the 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention [Abstract WELBB101] — point to a possible intervention.
The study involved 730 HIV-infected women in Botswana who were pregnant at the time of enrollment and planned to breast-feed. Those with CD4 counts ≥200 cells/mm3 were randomized to receive AZT/3TC/abacavir (Trizivir) or AZT/3TC (Combivir) + lopinavir/ritonavir from the third trimester through planned weaning at 6 months postpartum. Those with CD4 counts <200 cells/mm3 received AZT/3TC + nevirapin…